Effect of a potent cyclooxygenase inhibitor, 5-ethyl-4-methoxy-2-phenylquinoline (KTC-5), on human platelets

Journal of Pharmacy and Pharmacology

Volumn 54, Issue 7, 2002, Pages 967-974

  Liao, C H ^a,b   Chang, Y L ^b   Guh, J H ^b   Kuo, S C ^c   Huang, L J ^c   Teng, C M ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 5 ETHYL 4 METHOXY 2 PHENYLQUINOLINE; ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; CALCIUM; COLLAGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMIDAZOLE; INDOMETACIN; KTC 5; LIPOPOLYSACCHARIDE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBIN; THROMBOXANE B2; UNCLASSIFIED DRUG; 5-ETHYL-4-METHOXY-2-PHENYLQUINOLINE; QUINOLINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL LINE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; DRUG SPECIFICITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; IMMUNOBLOTTING; INHIBITION KINETICS; METABOLIC INHIBITION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; THROMBOCYTE; THROMBOCYTE AGGREGATION INHIBITION; CULTURE TECHNIQUE; ENZYMOLOGY; KINETICS; SECRETION; THROMBOCYTE AGGREGATION;

ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; BLOOD PLATELETS; CELL CULTURE TECHNIQUES; COLLAGEN; CYCLOOXYGENASE INHIBITORS; HUMANS; KINETICS; PLATELET AGGREGATION; QUINOLINES;

EID: 0035990602     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235702760089090     Document Type: Article

References (27)

1. Purification and properties of firefly luciferase
2. Cyclooxygenase in biology and disease
3. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase
4. Marked reduction in long-term cardiac deaths with aspirin after a coronary event. Multicenter Myocardial Ischemia Research Group
5. Aspirin therapy for cardiovascular disease
6. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2
7. How is the level of free arachidonic acid controlled in mammalian cells?
8. Activation of protein kinase C by oleic acid. Determination and analysis of inhibition by detergent micelles and physiologic membranes: Requirement for free oleate
9. Arachidonic acid and free fatty acids as second messenger and the role of protein kinase C
10. Synthesis of 4-alkoxy-2-phenylquinoline derivatives as potent antiplatelet agents
11. Effect of PP1D-1, a synthetic compound, on rabbit platelets
12. Antiangiogenic and antitumor activities of cyclooxygenase inhibitors
13. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
14. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cell
15. Phospholipid-mediated signalling in receptor activation of human platelets
16. Platelet aggregation II. Some results from a new method of study
17. Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes
18. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction
19. Nitric oxide activates cyclooxygenase enzymes
20. 2+ mobilization in bovine platelets
21. The lipoxygenase product, 5-hydroperoxy-arachidonic acid augments chemotactic peptide-stimulated arachidonic acid release from HL-60 granulocytes
22. Molecular mechanisms of platelet activation
23. Prostaglandin endoperoxide synthase: Structure and catalysis
24. Antiplatelet effect of butylidenephthalide
25. Inventory of exogenous factors affecting platelet aggregation isolated from plant sources. A report prepared on behalf of the Scientific and Standardization Committee's Registry of Exogenous Hemostatic Factors
26. Platelet-endothelial interactions in atherothrombotic disease: Therapeutic implications
27. Antiplatelet effects of Clausine-D isolated from Clausena excavata